Evidence map›Paper›PMID 32858234›Full record

ArticleThe ocular surface2020

Association of meibomian gland morphology with symptoms and signs of dry eye disease in the Dry Eye Assessment and Management (DREAM) study.

Ebenezer Daniel, Maxwell Pistilli, Gui-Shuang Ying, Vatinee Y Bunya, Mina Massaro-Giordano, Penny A Asbell, Maureen G Maguire, Dry Eye Assessment and Management (DREAM) Study Research Group

Abstract read
In one paragraph

Article in The ocular surface, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Diagnostic methods for managing dry eyes.World journal of methodology · 2025
    Article
  2. Article
  3. Impact of definition of meibomian gland dysfunction on the frequency of MGD in dry eye disease from the DREAM© study.Contact lens & anterior eye : the journal of the British Contact Lens Association · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Meibomian Gland Dysfunction Clinical Practice Guidelines.Japanese journal of ophthalmology · 2023
    Article
  8. Article
  9. Ocular surface disturbance in patients after acute COVID-19.Clinical & experimental ophthalmology · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ebenezer DanielDepartment of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: ebdaniel@pennmedicine.upenn.edu.
Maxwell PistilliDepartment of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA.
Gui-Shuang YingDepartment of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA.
Vatinee Y BunyaDepartment of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA.
Mina Massaro-GiordanoDepartment of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA.
Penny A AsbellHamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN, USA.
Maureen G MaguireDepartment of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA.
Dry Eye Assessment and Management (DREAM) Study Research Group

Funding

The Dry Eye Evaluation And Management (DREAM) Study: Coordinating CenterU10EY022879 · NEI · UNIVERSITY OF PENNSYLVANIA · PI MAGUIRE, MAUREEN G · 2013 to 2018
$7.3M
Dry Eye Evaluation and Management (DREAM) StudyU10EY022881 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ASBELL, PENNY · 2013 to 2020
$2.2M
Developing new methods for early detection of Sjogren's syndromeR01EY026972 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BUNYA, VATINEE Y · 2016 to 2020
$2.0M
NEI NIH HHS R01 EY026972NEI NIH HHS U10 EY022879NEI NIH HHS U10 EY022881
6 · The paper itself

Abstract

purposeTo describe associations between symptoms and signs of dry eye disease (DED) and meibomian gland (MG) morphology.

methodsCross-sectional study utilizing data from the Dry Eye Assessment and Management (DREAM) Study. Readers graded MG features in the middle third of upper and lower lids on infrared meibography images. Associations with signs and symptoms of DED were evaluated with adjustment for age and sex.

resultsAmong 268 patients, no MG features were associated with symptom scores (p > 0.08). Among 394 upper eyelids, better tear break-up times (<2, >2- <3.2and ≥ 3.2 s) were associated with more tortuous glands (mean (SD) 0.58(0.95), 0.83(1.2) and 1.14 (1.4), p = 0.01) and with higher scores on a composite score of MG features (21.90 (9.76), 23.29 (9.50), 26.26 (10.27); p = 0.02). Longer Schirmer test wetting lengths (0-5, >5-10, and >10 mm) were associated with increasing composite scores (22.02 (9.29), 23.80 (10.34), 24.96 (9.96), p = 0.03). Patients with Sjogren syndrome compared to other patients had fewer distorted MGs (mean 3.4 (2.3) vs 4.3 (2.3), p = 0.03) and fewer ghost glands (mean 0.33 (0.88) vs 0.89 (1.8), p = 0.006) in the upper lid.

conclusionIn the DREAM study, most MG morphologic features were not associated with the severity of DED symptoms or signs. Tortuous glands and a higher composite score for MG features were associated with longer tear break-up times and longer Schirmer test length in the upper eyelid only. Patients with Sjogren syndrome had fewer distorted and ghost glands.

Indexed as

Dry Eye SyndromesAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMeibomian GlandsMiddle AgedSjogren's SyndromeTearsYoung AdultDry eye diseaseMeibographyOcular surface disease indexTear function tests

Identifiers

PMID32858234
PMCPMC7686056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.